Nature, Published online: 13 February 2023; doi:10.1038/d41586-023-00393-7
An antibody treatment reduces measurements of brain abnormalities called amyloid plaques in people with Alzheimer’s disease, and lessens clinical decline. This result will help in developing therapies to treat and prevent the disease.
More News
Mapping genotypes to chromatin accessibility profiles in single cells – Nature
Alphafold 3.0: the AI protein predictor gets an upgrade
Full-colour 3D holographic augmented-reality displays with metasurface waveguides – Nature